JCM Webinar | At-Risk Mental States
Part of the Webinars on Clinical Medicine series
11 March 2026, 13:30 (CET)
11 March 2026
Psychosis, ARMS, UHR, Aberrant Salience, Long Acting
Welcome from the Chairs
20thJournal of Clinical Medicine Webinar
At-Risk Mental States
This webinar focuses on at-risk mental states (ARMSs) and pertains to the Special Issue in the Journal of Clinical Medicine. The program will address core psychopathological and clinical dimensions, with particular emphasis on aberrant salience mechanisms, the high rate of psychiatric comorbidity in ARMSs, and the clinical rationale and emerging evidence for the use of long-acting therapies. This webinar aims to provide an updated, evidence-based framework for early detection, risk stratification, and intervention strategies for individuals at risk for psychosis.
Date: 11 March 2026
Time: 1:30 pm CET | 8:30 pm CST Asia
Webinar ID: 880 8133 1435
Webinar Secretariat: journal.webinar@mdpi.com
Event Chairs
Department of Life Science, Health, and Health Professions, Link Campus University, Rome, Italy,
Department of Neuroscience, Head-Neck and Chest, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Giovanni Camardese is currently an Associate Professor of Psychiatry at Link Campus University in Rome, where he is actively engaged in teaching, research, and community outreach. He also collaborates with the Psychiatry Section of the Department of Neuroscience at the Fondazione Policlinico Universitario A. Gemelli in Rome where he now heads the Depression Disorders and Psychogastroenterology/Psychosomatic Medicine units. His research focuses on the neurobiology of mood disorders, including the dopamine synapse, neuroendocrine and immune–inflammatory responses, and the gut–brain axis. He has also developed personalized treatment and rehabilitation protocols for mood, anxiety, and addiction disorders in day hospital setting, additionally exploring chronotherapies, particularly light therapy, for mood disorders. He has served as principal investigator in numerous research projects and regularly presents his work at national and international conferences. He is the author of more than 160 scientific publications.
Department of Life Science, Health, and Health Professions, Link Campus University, Rome, Italy
Clinical Presentation of At-Risk Mental states
Michele Ribolsi is currently an Associate Professor of Psychiatry at Link Campus University in Rome and a Psychiatrist at the Department of Mental Health of ASL Roma 1. He was a Researcher from 2016 to 2020 at the University of Rome Tor Vergata and from 2020 to 2023 at Campus Bio-Medico University of Rome, where he is currently an Adjunct Professor. He served as a Consultant Psychiatrist at the Psychiatric Inpatient Unit (SPDC) of Policlinico Tor Vergata in 2020 and then as Head of the Psychiatry Service at the Campus Bio-Medico University Hospital Foundation from 2020 to 2023. Subsequently, from 2024 to 2025, he held the position of Medical Director at the Interuniversity Clinical Institute (Humanitas Consortium). He is the author of more than 80 scientific papers indexed in the SCOPUS database.
Keynote Speakers
Chair of Psychiatry, Department of Systems Medicine, Tor Vergata University of Rome,
Santa Lucia Foundation, IRCCS, Rome, Italy
Refining Psychosis Risk Screening: Aberrant Salience and Psychotic-Like Experiences in Help-Seeking Youth
Federico Fiori Nastro, MD, is an Italian psychiatrist and PhD candidate in Neuroscience at the University of Rome Tor Vergata. His clinical and research experience includes training at Imperial College London and consultant roles at Policlinico Tor Vergata and Fondazione Santa Lucia IRCCS. His main research interests focus on early detection and intervention in psychosis, as well as neuroscientific approaches to language alterations in major psychiatric and neurodevelopmental disorders.
The Paradigm Shift in the Clinical Use of Long-Acting Injectable Antipsychotics (LAIs)
Dr. Lorenzo Moccia is an Italian Psychiatrist based in Rome, currently working at the Unit of Psychiatry within the Fondazione Policlinico Universitario Agostino Gemelli IRCCS. He completed his residency in Psychiatry and earned a PhD in Neuroscience at the Università Cattolica del Sacro Cuore, after graduating in Medicine and Surgery from Sapienza Università di Roma. His clinical and research interests focus on neurocognition, eating disorders, schizophrenia spectrum disorders, behavioral addictions, and mind–body interactions. He teaches in university programs and specialist training schools, serves as an Editor for several scientific journals, and has authored 50+ peer-reviewed publications, along with book chapters and national conference presentations.
Registration
This is a FREE webinar. After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Certificates of attendance will be delivered to those who attend the live webinar.
Can’t attend? Register anyway and we’ll let you know when the recording is available to watch.
Program
|
Speaker/Presentation |
Time in CET |
Time in CST (Asia) |
|
Professor Giovanni Camardese and Professor Michele Ribolsi (Chairs) Chairs Introduction |
1:30 – 1:45 pm |
8:30 – 8:45 pm |
|
Professor Michele Ribolsi Clinical Presentation of At-Risk Mental states |
1:45 – 2:10 pm |
8:45 – 9:10 pm |
|
Dr. Federico Fiori Nastro Refining Psychosis Risk Screening: Aberrant Salience and Psychotic-Like Experiences in Help-Seeking Youth |
2:10 – 2:35 pm |
9:10 – 9:35 pm |
|
Dr. Lorenzo Moccia The Paradigm Shift in the Clinical Use of Long-Acting Injectable Antipsychotics (LAIs)
|
2:35 – 3:00 pm |
9:35 – 10:00 pm |
|
Q&A |
3.00 – 3:20 pm |
10:00 – 10:20 pm |
|
Prof. Giovanni Camardese & Prof. Michele Ribolsi (Chairs) Closing of Webinar |
3:20 – 3:25 pm |
10:20 – 10:25 pm |
Relevant Special Issue
Advances in Schizophrenia and Related Psychotic Disorders
Edited by Prof. Dr. Giovanni Camardese and Dr. Michele Ribolsi
Deadline for manuscript submissions: 25 March 2026
